PHASE I, OPEN-LABEL, DRUG INTERACTION STUDY TO EVALUATE THE EFFECT OF MULTIPLE DOSES OF KETOCONAZOLE ON SINGLE DOSE MIRABEGRON (YM178) ORAL CONTROLLED ABSORPTION SYSTEM (OCAS) IN HEALTHY ADULT SUBJECTS

被引：0

作者：

Sawamoto, T. ^{[1
]}

Lee, J. ^{[1
]}

Alak, A. ^{[1
]}

Meijer, J. ^{[2
]}

Roy, M. ^{[1
]}

Zha, J. ^{[1
]}

van Gelderen, M. ^{[2
]}

Marion, A. ^{[3
]}

Keirns, J. ^{[1
]}

机构：

[1] Astellas Global Res Dev, Deerfield, IL USA

[2] Astellas Global Res Dev, Leiderdorp, Netherlands

[3] MDS Pharma Serv US Inc, Omaha, NE USA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2011年 / 89卷

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：S21 / S21

页数：1

共 50 条

[31] An open-label, randomized single-dose, dose-proportionality study of oral doses of a sustained-release formulation of desvenlafaxine succinate in healthy subjects
Behrle, JA
Nichols, AI
McGrory, SB
Raible, D
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P82 - P82
[32] A phase I study of the effect of repeated oral doses of pantoprazole on the pharmacokinetics of a single dose of fedratinib in healthy male subjects
Ken Ogasawara
Bradley Vince
Christine Xu
Meng Zhang
Maria Palmisano
Gopal Krishna
Cancer Chemotherapy and Pharmacology, 2020, 85 : 995 - 1001
[33] A phase I study of the effect of repeated oral doses of pantoprazole on the pharmacokinetics of a single dose of fedratinib in healthy male subjects
Ogasawara, Ken
Vince, Bradley
Xu, Christine
Zhang, Meng
Palmisano, Maria
Krishna, Gopal
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 85 (05) : 995 - 1001
[34] A phase I, randomized, open-label, single-dose, 3-period crossover study to evaluate the drug-drug interaction between ZX008 (fenfluramine HCl oral solution) and a regimen of stiripentol, clobazam, and valproate in healthy subjects
Boyd, Brooks
Smith, Steven
Gammaitoni, Arnold
Galer, Bradley S.
Farfel, Gail M.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2019, 57 (01) : 11 - 19
[35] COADMINISTRATION OF CIMETIDINE WITH MIROGABALIN IN HEALTHY SUBJECTS: RESULTS FROM A PHASE I, RANDOMIZED, OPEN-LABEL, DRUG-DRUG INTERACTION STUDY.
Tachibana, M.
Yamamura, N.
Hsu, C.
Warren, V.
Dishy, V.
Zahir, H.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S49 - S49
[36] Absorption, Distribution, and Excretion of the Investigational Agent Orteronel (TAK-700) in Healthy Male Subjects: A Phase I, Open-Label, Single-Dose Study
Suri, Ajit
Pusalkar, Sandeepraj
Li, Yuexian
Prakash, Shimoga
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2016, 5 (03): : 180 - 187
[37] A phase 1, open-label study to evaluate the drug interaction between islatravir (MK-8591) and the oral contraceptive levonorgestrel/ethinyl estradiol in healthy adult females
Ankrom, Wendy
Jackson Rudd, Deanne
Zhang, Saijuan
Fillgrove, Kerry L.
Gravesande, Kezia N.
Matthews, Randolph P.
Brimhall, Darin
Stoch, S. Aubrey
Iwamoto, Marian N.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2021, 24 (12)
[38] Effects of Food on the Pharmacokinetic Properties of Surufatinib: A Phase I, Single-dose, Randomized, Open-label Crossover Study in Healthy Subjects
Qian, Hongjie
Wu, Xue
Chen, Qian
Li, Tingting
Wang, Wei
Jia, Jingying
Yu, Chen
Li, Ke
Sai, Yang
Su, Weiguo
Liu, Yanmei
CLINICAL THERAPEUTICS, 2020, 42 (09) : 1778 - 1786
[39] A PHASE 1, OPEN-LABEL, FIXED-SEQUENCE, CROSSOVER STUDY TO EVALUATE THE INTERACTION OF MULTIPLE-DOSE ODEVIXIBAT WITH THE PHARMACOKINETICS OF SINGLE-DOSE COMBINED ORAL CONTRACEPTIVE STEROIDS IN HEALTHY FEMALE PARTICIPANTS
Mazuir, Florent
Ordonez, Claudia
Wallefors, Terese
Zhu, Judy
Lindstrom, Erik
HEPATOLOGY, 2024, 80 : S1773 - S1774
[40] A phase I, single-center, randomized, open-label, three-period crossover study to evaluate the drug-drug interaction between ZSP1273 and oseltamivir in healthy Chinese subjects
Pang, Yanqing
Li, Haijun
Chen, Xuemei
Cao, Yingying
Jiang, Hui
Huang, Jufang
Liu, Yiming
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2025, 69 (04)

← 1 2 3 4 5 →